Está disponible para descarga el artículo sobre Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum, de la Asociación Americana de Tiroides.
Publicaciones Similares
Guidelines Osteoporosis
PorSadeno
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update from the American College of Physicians Descarga aquí el artículo
Artículo Diamond Study Group
PorSadeno
Está disponible para descarga el artículo Effect of Continuous Glucose Monitoring on Glycemic Control in Adults with Type 1 Diabetes Using Insulin Injections. Autores: RoyW. Beck, MD, PhD; Tonya Riddlesworth, PhD; Katrina Ruedy, MSPH; Andrew Ahmann, MD; Richard Bergenstal, MD; Stacie Haller, RD, LD, CDE; Craig Kollman, PhD; Davida Kruger, MSN, APN-BC; Janet B….
Rueda por la Diabetes al Mont Blanc, con el Doctor Delgado
PorSadeno
El Doctor Elías Delgado, coordinador de Diabetes del Servicio de Endocrino del HUCA, participó el pasado mes de septiembre en el programa ‘Rueda por la Diabetes al Mont Blanc’, una ruta en bicicleta de montaña con personas con Diabetes Mellitus Tipo 1. El Doctor Delgado cuenta su experiencia en este post: El Tour del…
Standards or Medical Care in Diabetes 2017
PorSadeno
Consulta aquí el artículo Standards or Medical Care in Diabetes 2017, publicado por la American Diabetes Association
Evolocumab and Clinical Outcomes in Patients with Card. Disease
PorSadeno
Descargue el artículo completo ABSTRACT BACKGROUND Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%. Whether it prevents cardiovascular events is uncertain. METHODS We conducted a randomized, double-blind, placebo-controlled trial involving 27,564 patients with atherosclerotic cardiovascular disease and LDL cholesterol levels…
Evidencias de los nuevos tratamientos para el colesterol
PorSadeno
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial LDL cholesterol is a well established risk factor for atherosclerotic cardiovascular disease. How much one should or safely can lower this risk factor remains debated. We aimed to explore the relationship between progressively lower…
